We examined for the first time epitopes at which Tau is hyperphosphorylated in Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease, and also select Tau kinases. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.